Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial | Zendy

Warangkana Keeratichanat | Zendy; Apichat Kaewdech | Zendy; Suriya Keeratichanat | Zendy

Open Access

Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial

Author(s) -

Warangkana Keeratichanat,

Apichat Kaewdech,

Suriya Keeratichanat

Publication year - 2018

Publication title -

therapeutic advances in respiratory disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.022

H-Index - 37

eISSN - 1753-4666

pISSN - 1753-4658

DOI - 10.1177/1753466618816625

Subject(s) - medicine , pleurodesis , talc , malignant pleural effusion , surgery , anesthesia , randomized controlled trial , adverse effect , saline , autologous blood , lidocaine , pleural effusion , materials science , composite material

ABP had an equivalent efficacy compared to talc pleurodesis for MPE treatment. ABP offered less fever and pain and could shorten hospital stays, and neither produced means ABP did not produce clotted drainage, pulmonary or systemic adverse events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research